Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changchun Pulike Biological Pharmaceutical is a high-tech enterprise specializing in the research, development, and manufacturing of veterinary biological products. As a key subsidiary of Pulike Biological Engineering, the company focuses on advanced animal vaccines and diagnostic reagents, particularly for swine and poultry diseases. Its facilities are designed to meet high-level biosafety standards, enabling the production of high-efficiency vaccines such as those for foot-and-mouth disease and swine influenza. The company plays a significant role in the Chinese animal health market by integrating modern biotechnology with large-scale industrial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changchun Pulaike Pharmaceutical Biotechnology.